Publication:
Optimization of piribedil mucoadhesive tablets for efficient therapy of Parkinson-s disease: physical characterization and ex vivo drug permeation through buccal mucosa

Simple item page
dc.contributor.authorCelik, BURAK
dc.contributor.authorOzdemir, Samet
dc.contributor.authorDemirkoz, Asli Barla
dc.contributor.authorUner, Melike
dc.contributor.institutionauthorÇELİK, BURAK
dc.date.accessioned2019-10-05T14:27:57Z
dc.date.available2019-10-05T14:27:57Z
dc.date.issued2017-01-01
dc.description.abstractObjective: The aim of this study was optimization of buccal piribedil (PR) mucoadhesive tablets to improve its low bioavailability and provide controlled release for the treatment of Parkinson-s disease.
dc.description.sponsorshipBezmiâlem Vakıf Üniversitesi
dc.identifier
dc.identifier.citationCelik B., Ozdemir S., Demirkoz A. B. , Uner M., -Optimization of piribedil mucoadhesive tablets for efficient therapy of Parkinson-s disease: physical characterization and ex vivo drug permeation through buccal mucosa-, DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, cilt.43, ss.1836-1845, 2017
dc.identifier.pubmed28665152
dc.identifier.urihttps://hdl.handle.net/20.500.12645/3961
dc.language.isoen
dc.titleOptimization of piribedil mucoadhesive tablets for efficient therapy of Parkinson-s disease: physical characterization and ex vivo drug permeation through buccal mucosa
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameB-ENT
local.avesis.id60461227-82f6-4858-96b3-1293144af8bd
local.avesis.response3831
local.indexed.atPubMed
relation.isAuthorOfPublicationfb8ce36b-f920-4f90-a8b5-ea24535e608d
relation.isAuthorOfPublication.latestForDiscoveryfb8ce36b-f920-4f90-a8b5-ea24535e608d

Files

Collections

Yayınlar - Eserler
Eczacılık Fakültesi